Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046074
Filing Date
2025-03-27
Accepted
2025-03-27 16:12:19
Documents
104
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kytx-20241231.htm   iXBRL 10-K 3908625
2 EX-10.8 kytx-ex10_8.htm EX-10.8 153011
3 EX-10.16 kytx-ex10_16.htm EX-10.16 43658
4 EX-19.1 kytx-ex19_1.htm EX-19.1 179261
5 EX-23.1 kytx-ex23_1.htm EX-23.1 3879
6 EX-31.1 kytx-ex31_1.htm EX-31.1 17386
7 EX-31.2 kytx-ex31_2.htm EX-31.2 17381
8 EX-32.1 kytx-ex32_1.htm EX-32.1 11552
9 EX-32.2 kytx-ex32_2.htm EX-32.2 10943
10 GRAPHIC img188508218_0.jpg GRAPHIC 433873
11 GRAPHIC img188508218_1.jpg GRAPHIC 366578
12 GRAPHIC img188508218_2.jpg GRAPHIC 400109
13 GRAPHIC img188508218_3.jpg GRAPHIC 205690
14 GRAPHIC img188508218_4.jpg GRAPHIC 697306
15 GRAPHIC img188508218_5.jpg GRAPHIC 435218
16 GRAPHIC img188508218_6.jpg GRAPHIC 855477
17 GRAPHIC img188508218_7.jpg GRAPHIC 430899
18 GRAPHIC img188508218_8.jpg GRAPHIC 608957
19 GRAPHIC img188508218_9.jpg GRAPHIC 778725
20 GRAPHIC img188508218_10.jpg GRAPHIC 850800
21 GRAPHIC img188508218_11.jpg GRAPHIC 865924
22 GRAPHIC img188508218_12.jpg GRAPHIC 970122
23 GRAPHIC img188508218_13.jpg GRAPHIC 883
24 GRAPHIC img251394553_0.jpg GRAPHIC 9608
25 GRAPHIC img251394553_1.jpg GRAPHIC 10458
  Complete submission text file 0000950170-25-046074.txt   32987907

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kytx-20241231.xsd EX-101.SCH 1454336
107 EXTRACTED XBRL INSTANCE DOCUMENT kytx-20241231_htm.xml XML 1961105
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41947 | Film No.: 25779395
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)